This brand name is authorized in France, New Zealand, Romania, Tunisia, United Kingdom
The drug ACUPAN contains one active pharmaceutical ingredient (API):
1
Nefopam
UNII 685J48E13W - NEFOPAM HYDROCHLORIDE
|
|
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ACUPAN Tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02BG06 | Nefopam | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FR | Base de données publique des médicaments | Identifier(s): 62580656 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2482 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W43861001, W43861002 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5193031 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.